Peter Slavin, who ran Massachusetts General Hospital in Boston for nearly two decades before stepping down in 2021, has taken a new job heading up
Health care provider Optum has backed away from its plan to purchase Steward Health Care’s national physicians group, dealing a major setback to Steward’s efforts
Next stop: Beacon Hill. Governor Maura Healey’s long-awaited plan to double down on state funding for the biotech and medical technology sector came into focus
CAMBRIDGE, Mass. — The increasingly adversarial relationship between the United States and China has raised national security concerns about Chinese penetration into key sectors of
WATERTOWN — Their brainstorming began in an MIT class in 2010 when the eager undergrads shot each other emails about how to solve a bioengineering
Move over, Kendall Square. Folks in the biotech nerve center may shudder at the notion. But the next miracle drug for lung cancer or epilepsy
Veteran biotech entrepreneur Harvey Berger, who has been on the sidelines for the past five years, is returning to the fray as chief executive of
CAMBRIDGE — Vietnamese-born entrepreneur Jean Pham is “graduating” from LabCentral, a biotech launchpad on the edge of Kendall Square, after enjoying free lab space for
The state’s celebrated cluster of biotechs has hatched breakthrough medicines for everything from COVID and cystic fibrosis to multiple rare diseases. It has pioneered cutting-edge
The fight over drug prices is far from over. Investors in biopharma companies, who lobbied vigorously — but unsuccessfully — against allowing Medicare to negotiate drug